FDA Zaps Tongue Nerve Stimulators into Moderate Regulation Category
Published Date: 12/19/2025
Rule
Summary
The FDA is officially classifying the electrical tongue nerve stimulator, a device that helps people with movement problems, as a Class II device with special safety rules. This change makes it easier and faster for patients to get this innovative treatment by reducing some regulatory hurdles. The new classification is effective December 19, 2025, and could speed up device availability without extra costs for users.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Class II ruling speeds patient access
The FDA classified the electrical tongue nerve stimulator as a Class II device with special controls, which the agency says will enhance patients' access and reduce regulatory burdens. The final order is effective December 19, 2025, and FDA states this classification can make it easier and faster for patients to get this treatment.
Creates predicate for future devices
Because FDA classified this device via the De Novo process, the electrical tongue nerve stimulator can serve as a predicate device. Future device sponsors can use the less-burdensome 510(k) process instead of a De Novo request or premarket approval, lowering regulatory hurdles for companies making similar devices.
Manufacturers must meet special controls
To be classified as Class II, manufacturers must meet special controls including biocompatibility testing for patient-contacting components; electromagnetic, battery, electrical, mechanical, and thermal safety testing; non-clinical performance testing of stimulation parameters; software verification/validation and cybersecurity assessment; and specific labeling (technical summary, instructions, cleaning, storage, charging, disposal).
Device is prescription-only
The FDA states the electrical tongue nerve stimulator is a prescription device. That means the device is available only with a prescription and is exempt from layperson 'adequate directions for use' requirements under specified statutory provisions.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-13047 — Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-13820 — Determination That TOVALT ODT (Zolpidem Tartrate) Orally Disintegrating Tablets, 5 Milligrams and 10 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that TOVALT ODT tablets (5 mg and 10 mg) weren’t taken off the market because of safety or effectiveness problems. This means generic drug makers can now apply to sell their own versions, making it easier and cheaper for people who need this sleep aid. If approved, more affordable options could hit the shelves soon, helping patients and saving money.
2026-13778 — Medical Device User Fee Amendments; Public Meeting; Request for Comments
The FDA is planning a public meeting on August 5, 2026, to talk about renewing fees that medical device makers pay to help speed up device reviews from 2028 to 2032. This affects companies making medical devices and could impact how much they pay and how fast their products get approved. The current fee program ends in September 2027, so the FDA wants your thoughts before finalizing new rules and fees.
2026-13716 — New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of Sponsor
The FDA just updated the rules for new animal drugs, approving several new and generic medicines for pets and farm animals from early 2026. These changes help keep animal treatments safe and effective, and the updates take effect right away on July 7, 2026. If you’re a drug maker or animal caretaker, these approvals and sponsor changes could impact what medicines are available and when.
2026-13534 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Administrative Practices and Procedures; Formal Hearings
The FDA is asking for public feedback on how it collects information for formal hearings and administrative rules. This affects businesses and people who interact with the FDA, with no new costs but a chance to improve paperwork processes. Comments are due by August 5, 2026, so don’t miss your chance to weigh in!
2026-13616 — Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications
The FDA is officially pulling the plug on 34 drug approvals because the companies stopped selling these medicines. This change kicks in on August 5, 2026, and it mainly affects drug makers like Endo Operations and Pfizer. No money penalties here—just a clean break, but companies can ask to reapply if they want to bring the drugs back.
Previous / Next Documents
Previous: 2025-23412 — Safety Zone; Fireworks Display, Ohio River Mile Marker 73 to 74, Wellsburg, WV
The Coast Guard is setting up a temporary safety zone on the Ohio River near Wellsburg, WV, from 11 p.m. on December 31, 2025, to 1 a.m. on January 1, 2026, to keep everyone safe during the New Year's Eve fireworks show. Boats and people can’t enter this area unless they get special permission. This quick action helps prevent accidents from fireworks and keeps the river safe without causing delays or costs.
Next: 2025-23414 — Falsification, Reproduction, Alteration, Omission, or Incorrect Statements
The FAA fixed a rule mix-up that accidentally deleted whole sections instead of just small parts about lying or messing with official aviation documents. This fix puts those sections back where they belong, affecting airlines, flight schools, and commercial space operators. The corrected rules take effect December 19, 2025, so everyone should update their records to avoid trouble.